IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has announced a strategic collaboration with the contract research organization arm of Sarah Cannon Research Institute, SCRI Development Innovations, aimed at transforming oncology trials for biopharma partners worldwide. By combining the capabilities of IQVIA and SCRI Development Innovations, this collaboration will enhance clinical trial processes, eliminate operational hurdles, accelerate data delivery and expedite the availability of cutting-edge therapies to patients.
The collaboration leverages IQVIA's global reach and precision in managing one in five oncology trials in the United States, along with its ability to seamlessly integrate data, technology and analytics. These capabilities are combined with SCRI Development Innovations' community oncology expertise, and enhanced operational model, Accelero, which expedites trial activation and enhances recruitment for SCRI sites in the United States. Additionally, the Accelero model seamlessly integrates data from the electronic health record to the electronic data capture systems for U.S. clinical trial data collection. Together, these strengths offer sponsors a more effective pathway to operationalize the development of innovative treatments for patients.
'We are excited to announce our collaboration with SCRI Development Innovations,' said Richard Staub, president of Research & Development Solutions at IQVIA. 'This collaboration embodies our commitment to innovation, efficiency and delivering of superior outcomes for patients by bringing together the best of both organizations and eliminating the complexities often associated with multiple vendors. Together we will accelerate the development of new cancer therapies and improve outcomes for patients worldwide.'
'We are enthusiastic about the impact we can make in transforming clinical trial delivery through our collaboration with IQVIA,' said Dee Anna Smith, chief executive officer at Sarah Cannon Research Institute. 'Through our accelerated operations model, Accelero, SCRI can alleviate the operational burden on research sites, enhance enrollment and expedite data delivery through our cutting-edge technology solutions. Additionally, we will leverage IQVIA's global reach, expertise and capabilities in trial design and recruitment to provide a seamless global delivery model for our partners.'
The collaboration between IQVIA and SCRI Development Innovations marks a significant step forward in transforming oncology trial delivery globally. Visit IQVIA at Booth 14103 or SCRI at Booth 27022 during the American Society of Clinical Oncology (ASCO) Annual Meeting May 30 to June 3 in Chicago, Ill., to learn more about this innovative partnership to advance cancer research and improve patient outcomes.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA's portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI ®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
About Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world's leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI's research network brings together more than 1,300 physicians who are actively accruing patients to clinical trials at more than 250 locations in 24 states across the U.S. Visit scri.com to learn more.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Boeing's $444 Million Gamble: Will One Judge Shatter the Deal That Saves It From Criminal Trial?
Boeing (NYSE:BA) just made a move that could wipe a years-long legal headache off its booksbut only if a federal judge signs off. The company has reached a tentative deal with the U.S. Department of Justice that would let it avoid prosecution for misleading regulators over the 737 Max crashes in 2018 and 2019. The agreement, revealed in a securities filing, includes $444.5 million in compensation to victims' families and allows Boeing to withdraw its earlier guilty plea. On paper, it looks like a clean break. In reality? It's anything but done. Warning! GuruFocus has detected 6 Warning Signs with BA. That's because the families of the crash victims aren't letting this slide. They've challenged the agreement, arguing it's far too lenient and strips them of their right to a real reckoning. The judge overseeing the case, Reed O'Connor, has already disrupted prior deals over lack of transparency and weak oversight. He's now giving families until June 18 to file formal objections, and the DOJ and Boeing will have just one week to counter. It's a tight windowand a tense one. This legal saga dates back to a deferred prosecution deal from 2021, when Boeing paid $2.5 billion and promised reform. That plan nearly ran its courseuntil January 2024, when a 737 Max door blew off midflight and reignited public and prosecutorial fury. Now, Boeing's shot at resolution depends entirely on one courtroom. If the deal sticks, it could help the company reset its reputation and rebuild investor trust. But if it collapses, Boeing could be staring at a full-blown criminal trialwith all the volatility that brings. This article first appeared on GuruFocus.
Yahoo
20 minutes ago
- Yahoo
Wall Street Still Loves This Stock--Even After It Crashed nearly 18% in a Day
PVH Corp (NYSE:PVH) just got hammereddown nearly 18% at 12.22pm. The selloff came despite a blockbuster year: record gross margins of 59.4%, $600 million in free cash flow, and a 10% operating margin. Non-GAAP EPS for fiscal 2024 came in at a record $11.74, up 10% from last year. The company even returned $500 million to shareholders through buybacks. On paper, these are the kinds of numbers that should get a standing ovation. Instead, investors hit the exits. So what's going on? A few storm clouds are hanging over the 2025 outlook. Management is guiding for flat to slightly higher revenue, and while EPS could rise to $12.75, the road ahead looks bumpier. Freight costs are ticking up, promotions are likely to intensify, and Chinaone of PVH's key marketsis facing a slowdown post-holiday. To make matters worse, PVH was added to China's unreliable entity list by MOFCOM, introducing a new layer of geopolitical risk. Calvin Klein also ran into product development delays, adding short-term margin pressure to the mix. And yetWall Street hasn't given up. The average price target from 13 analysts sits at $98.23, implying a potential 48.9% upside from current levels. GuruFocus places PVH's fair value at $97.10. Brokerage consensus is still Outperform. Underneath the headline drop, there are signals of strength: EBIT surged over 40% in North America, Europe's store traffic picked up in back-to-back quarters, and core product sell-through is improving. This might just be a stock investors don't like right nowbut could end up regretting not buying later. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
Make Father's Day Extra Special with Kroger
Retailer highlights all the ways to surprise and delight dad leading up to Father's Day CINCINNATI, June 5, 2025 /PRNewswire/ -- The Kroger Co. (NYSE: KR), America's grocer, today shared how customers can celebrate dad with random acts of kindness leading up to Father's Day. From a delicious meal on the grill to a basket of hot sauce and cold beverages, dad deserves the extra love and appreciation this holiday. "We can all agree dads deserve more than a single day of recognition, so we're sharing all the ways to celebrate the special guy ahead of Father's Day," said Mary Ellen Adcock, Kroger executive vice president and chief merchant and marketing officer. "This Father's Day, Kroger is here to help honor and give thanks to all the dads in our lives by surprising and delighting him with his favorite things." Brighten up dad's week leading up to Father's Day with these simple, yet meaningful ideas: Grill up a delicious meal: Fire up the grill and invite family to celebrate dad with a grill out. Find inspiration for sauces, sides, fresh meats and desserts on Kroger's blog, The Fresh Lane, including grilled corn recipes, a homemade bourbon BBQ sauce and even a meat calculator. Pick up donuts for dad: Make Father's Day extra special with a wide selection of donuts from Kroger's bakery. From classic glazed yeast donuts to indulgent Boston cream-filled mini donuts, surprise dad with his favorite treats and make his day extra sweet. Deliver a basket of hot sauce and cold drinks: Spice up this Father's Day with an assortment of gourmet hot sauces and cool down with a wide selection of craft beers and beverages, including Kroger Fizz Sparkling Water and Kroger Real Brewed Raspberry Tea. Choose two of dad's favorites for the ultimate fire and ice combo. Fill up his tank: Surprise dad by filling up his gas tank for a change and all the times he has doled out gas money. Surprise dad with a gift card: Whether dad wants new golf shoes or a new toolbox, treat dad to choose his own Father's Day present with a gift card. Kroger offers a wide selection of gift cards from hundreds of stores, allowing dad to choose his favorite while earning 4X fuel points from June 4-17. No matter the gift, be sure to complete the celebration with a greeting card expressing a heartfelt message. Find even more Father's Day inspiration at Kroger's blog, The Fresh Lane brimming with grill out recipes, party essentials and even more gift ideas for dad. Shopping at Kroger, customers will see lower prices on more than 1,000 items across the store in addition to everyday low prices and more than $600 in digital coupons available each week. With Kroger's Fresh & Quality Guarantees, customers never have to compromise high-quality for low prices. About KrogerAt The Kroger Co. (NYSE: KR), we are dedicated to our Purpose: To Feed the Human Spirit™. We are, across our family of companies more than 400,000 associates who serve over 11 million customers daily through an e-commerce experience and retail food stores under a variety of banner names, serving America through food inspiration and uplift, and creating #ZeroHungerZeroWaste communities. To learn more about us, visit our newsroom and investor relations site. View original content to download multimedia: SOURCE The Kroger Co. Sign in to access your portfolio
